Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Traffic (Copenhagen, Denmark)
|
August 18, 2009
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways
Sonja I Buschow, Esther N M Nolte-'t Hoen, Guillaume van Niel, et al.
Nature Immunology
|
October 14, 2008
Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells
Louise J Young, Nicholas S Wilson, Petra Schnorrer, et al.
British Journal of Haematology
|
February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
Saskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Cancer Immunology Research
|
September 27, 2015
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Arianne M Brandsma, Toine Ten Broeke, Maaike Nederend, et al.
Cancer Immunology Research
|
November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition
Louise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Neuro-Oncology Advances
|
July 24, 2025
Dual targeting of <i>CD155</i>/<i>TIGIT</i> and <i>PD-L1</i>/<i>PD-1</i> immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma
Matthijs Monnikhof, Michael Y Schakelaar, Chris Meulenbroeks, et al.
The Journal of Experimental Medicine
|
October 15, 2024
Uniting education, research, healthcare, and society to advance women's heart health
Michael Y Schakelaar, Annemieke Maas, Anne-Mar L N van Ommen, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Blood Advances
|
September 15, 2021
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20
Mitchell Evers, Thies Rösner, Anna Dünkel, et al.
Traffic (Copenhagen, Denmark)
|
August 18, 2009
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways
Sonja I Buschow, Esther N M Nolte-'t Hoen, Guillaume van Niel, et al.
Nature Immunology
|
October 14, 2008
Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells
Louise J Young, Nicholas S Wilson, Petra Schnorrer, et al.
British Journal of Haematology
|
February 23, 2018
New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies
Saskia Meyer, Mitchell Evers, Johannes H M Jansen, et al.
Cancer Immunology Research
|
September 27, 2015
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing
Arianne M Brandsma, Toine Ten Broeke, Maaike Nederend, et al.
Cancer Immunology Research
|
November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition
Louise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Neuro-Oncology Advances
|
July 24, 2025
Dual targeting of <i>CD155</i>/<i>TIGIT</i> and <i>PD-L1</i>/<i>PD-1</i> immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastoma
Matthijs Monnikhof, Michael Y Schakelaar, Chris Meulenbroeks, et al.
The Journal of Experimental Medicine
|
October 15, 2024
Uniting education, research, healthcare, and society to advance women's heart health
Michael Y Schakelaar, Annemieke Maas, Anne-Mar L N van Ommen, et al.
Page
of 3